These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 18036064

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M, Jarosz-Chobot P, Małecka-Tendera E, Deja G.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [Abstract] [Full Text] [Related]

  • 5. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N, Shashaj B.
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
    González-Romero S, González-Molero I, Fernández-Abellán M, Domínguez-López ME, Ruiz-de-Adana S, Olveira G, Soriguer F.
    Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [Abstract] [Full Text] [Related]

  • 10. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M, Ruxer J, Loba J, Siejka A, Markuszewski L.
    Adv Med Sci; 2006 Sep; 51():133-6. PubMed ID: 17357293
    [Abstract] [Full Text] [Related]

  • 11. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC, Sutton AJ.
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
    Simon B, Treat V, Marco C, Rosenberg D, Joseph J, Hipszer B, Li Y, Chervoneva I, Padron-Massara L, Jabbour S.
    Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
    [Abstract] [Full Text] [Related]

  • 15. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA, Francis G, Lawson-Wilkins Drug and Therapeutics Committee.
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
    Monami M, Lamanna C, Marchionni N, Mannucci E.
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
    [Abstract] [Full Text] [Related]

  • 19. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y, Lerner-Geva L, Modan-Moses D, Graph-Barel C, Mazor-Aronovitch K, Boyko V, Pinhas-Hamiel O.
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.